 |  |
Program Plenary and Invited Speakers  Final Program |
Plenary Speakers 
Stefano Bertozzi, Ph.D.Dean, School of Public Health and Professor of Health Policy & Management University of California, Berkeley, USA Title: PUBLIC HEALTH POLICY AND MANAGEMENT: KEYS TO FUTURE HEALTHCARE 
Chad Mirkin, Ph.D.Director of the International Institute of Nanotechnology Northwestern University, USA NANOTECHNOLOGY: DELIVERING THE PROMISE IN THE FUTURE OF HEALTHCARE 
Mark Zdeblick, Ph.D.Co-Founder, CTO Proteus Digital, USA Title: AN INTERNATIONAL FRAMEWORK FOR WIRELESS HEALTHCARE INNOVATION Invited Speakers 
Mark Allen, Ph.D.Inaugural Scientific Director of the Singh Center for Nanotechnology, Professor of Electrical & Systems Engineering and Mechanical & Applied Sciences University of Pennsylvania, USA Title: BIOMEDICAL MEMS IMPLANTS: INORGANIC-BASED, POLYMER-BASED, AND PROTEIN-BASED TRANSDUCERS 
Piotr GrodzinskiNCI Alliance for Nanotechnology in Cancer, USA Title: NANOTECHNOLOGY-BASED THERAPEUTICS AND DIAGNOSTICS FOR CANCER - FROM ACADEMIC RESEARCH TO CLINICAL AND COMMERCIAL OUTCOMES - VIEW FROM THE NCI ALLIANCE FOR NANOTECHNOLOGY IN CANCER 
Amy Herr, Ph.D.Lester John & Lynne Dewar Lloyd Distinguished Professor University of California, Berkeley, USA Title: SURMOUNTING THE DIAGNOSTIC BIOMARKER CHALLENGE 
Stefanie Jeffrey, M.D.Professor of Surgery & Chief of Surgical Oncology Research Stanford University, USA Title: OPPORTUNITIES FOR NEW TECHNOLOGIES IN ONCOLOGY 
Ellis MengProfessor and Dwight C. and Hildagarde E. Baum Chair University of Southern California Title: IMPLANTABLE MICRO INFUSION PUMPS FOR CHRONIC LOCALIZED DELIVERY OF ANTI-CANCER THERAPIES 
Jeffrey Rogers, Ph.D.Director of Engineering, Healthcare Technologies Google, USA Title: THE BATTLEFIELD-A DRIVER AND CRUCIBLE OF HEALTHCARE INNOVATION 
Mehmet Toner, Ph.D.Professor of Surgery, Massachusetts General Hospital, Professor or Biomedical Engineering, Harvard-MIT Health Sciences and Technology Program, USA Title: FUTURE OF MANAGING CANCER PATIENTS: MICROFLUIDIC QUEST TO FIND EXTREMELY RARE CIRCULATING TUMOR CELLS |